PATENT CLAIM ANALYSIS

Application Number: 15760878
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-11
Patent Classification: ["424", "186100"]

Abstract:
Provided are polypeptides derived from the coronaviruses (CoVs) Spike protein (S) characterized by high affinity and specificity the S receptor and its neutralizing antibodies. Further provided are compositions and vaccines, and vaccine-based therapies targeting CoVs, and SARS and MERS viruses in particular.

Claim (Index 46):
The polypeptide according to  claim 43 , wherein said Coronavirus is Severe Acute Respiratory Syndrome coronavirus (SARS CoV), and wherein said native RBM comprises residues 432 to 486 of the SARS-CoV Spike protein as denoted by SEQ ID NO: 3 and wherein said tacking segment is an amino acid loop comprising residues 444 to 459 of the SARS-CoV Spike protein as denoted by SEQ ID NO: 2.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 1.35135
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15306617', '10997201', '14375083', '15553466', '14717760']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7891565573917395
- 35 USC 102 Novelty (BERT): 0.5602754123109386
- Combined Prediction Score: 0.7662684428836595
- Mean Citation Score: 451.928406
- Max Citation Score: 490.51212
- Similarity Product: 330.30065052672387

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test